Recently the FDA began a review of trial results for the experimental drug Ampligen® as a therapy for Chronic Fatigue Syndrome (ME/CFS). This means that after many years of trials involving various leading ME/CFS specialists, within a few months this drug might become the first to be approved for prescription to patients in the US. If this comes about, ME/CFS patients and their physicians will have some collaborative decisions to make.
If you have a diagnosis of ME/CFS, please take a moment to complete this brief, anonymous survey. Check all boxes that apply.